Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

View source ↗

Summary

Prospective validation study of the novel PVD-B65 risk score in patients with chronic lung disease and pulmonary hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Temple University | Conditions: Chronic Lung Disease, Pulmonary Hypertension | Status: RECRUITING